Not available
Quote | Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA)
Last: | $38.22 |
---|---|
Change Percent: | 0.58% |
Open: | $38.21 |
Close: | $38.22 |
High: | $38.24 |
Low: | $38.21 |
Volume: | 5,540,025 |
Last Trade Date Time: | 12/27/2021 04:55:08 pm |
News | Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA)
Novo Nordisk today announced that the acquisition of Dicerna Pharmaceuticals, Inc. (Dicerna; Nasdaq: DRNA), announced on 18 November 2021, has been completed. Following the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has today acquired all outstan...
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Novo Nordisk’s cash tender offer for Dicerna expired at 11:59 p.m., Easter...
Message Board Posts | Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA)
Subject | By | Source | When |
---|---|---|---|
znewcar1: DRNA 78% v32,1M c38.03 f77,8M H38.14 | znewcar1 | investorshangout | 11/18/2021 11:15:15 PM |
Vindicated on this one today. Being bought | ok2buy | investorshub | 11/18/2021 5:12:24 PM |
whytestocks: $DRNA News Article - LCID, RIVN, FSR: Why Are EV Stocks Down Today? | whytestocks | investorshangout | 11/18/2021 4:15:45 PM |
whytestocks: $DRNA News Article - Dicerna Merger Investigation: Halper Sadeh LLP Announces Investiga | whytestocks | investorshangout | 11/18/2021 3:45:47 PM |
whytestocks: $DRNA News Article - DRNA Stock: The $3B Novo Nordisk Deal That Has Dicerna Pharma Shar | whytestocks | investorshangout | 11/18/2021 3:35:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Dicerna Pharmaceuticals Inc. Company Name:
DRNA Stock Symbol:
NASDAQ Market:
Dicerna Pharmaceuticals Inc. Website:
Novo Nordisk today announced that the acquisition of Dicerna Pharmaceuticals, Inc. (Dicerna; Nasdaq: DRNA), announced on 18 November 2021, has been completed. Following the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has today acquired all outstan...
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Novo Nordisk’s cash tender offer for Dicerna expired at 11:59 p.m., Easter...
Direxion Launches mRNA ETF (MSGR) MSGR Offers Exposure to Rapidly Evolving mRNA Sector PR Newswire NEW YORK , Dec. 9, 2021 /PRNewswire/ -- Direxion announced today the launch of the Direxion mRNA ETF (Ticker: MSGR) . MSGR invests in companies ...